LifeStance Health (LFST) Equity Average (2020 - 2026)

LifeStance Health (LFST) has 7 years of Equity Average data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Equity Average rose 3.27% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 3.27% YoY) and the FY2025 annual result came in at $1.5 billion, up 3.2% from the prior year.
• Equity Average fell to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Equity Average topped out at $1.5 billion in Q1 2022 and bottomed at $1.4 billion in Q1 2024.
• The 5-year median for Equity Average is $1.5 billion (2025), against an average of $1.5 billion.
• The widest annual swing landed in 2022, when Equity Average soared 58.19%; it then declined 5.49% in 2024.
• Tracing LFST's Equity Average over 5 years: stood at $1.5 billion in 2022, then declined by 5.45% to $1.4 billion in 2023, then fell by 0.02% to $1.4 billion in 2024, then climbed by 4.52% to $1.5 billion in 2025, then dropped by 0.51% to $1.5 billion in 2026.
• Per Business Quant, the three latest LFST Equity Average figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).

Peer Comparison